Nicholas Piramal to divest stake in R&D biz

19599 Investors following Dr Reddys Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Nicholas Piramal to divest stake in R&D biz

After Dr Reddy's and Sun Pharma, it's now Nicholas Piramal's turn to consider unlocking value of its R&D business.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from India Business Hour on CNBC-TV18 Watch the full show » ALSO READ See latest News about Dr Reddys Labs See previous management interviews See what other Experts & Brokerages are saying about Dr Reddys Labs Dr Reddys Labs BSE | NSE 25/05/12 Are Mutual Funds betting on Dr Reddys Labs? Other Stocks in this news Piramal Healthcare | Sun Pharmaceutical Industries |

After Dr Reddy's and Sun Pharma , it's now Nicholas Piramal 's turn to consider unlocking value of its R&D business.

Sources say the group may divest stake to a private equity player. The R&D business is pegged at around USD 200 million. The company is expected to use the funds to strengthen its research and discovery pipeline . When contacted, Nicholas Piramal officials refused to comment on the news.

Disclaimer: This is source-based information and has not been provided to the stock exchange